These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17692431)

  • 1. Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement.
    Frey V; Viaud J; Subra G; Cauquil N; Guichou JF; Casara P; Grassy G; Chavanieu A
    Eur J Med Chem; 2008 May; 43(5):966-72. PubMed ID: 17692431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photocontrollable peptide-based switches target the anti-apoptotic protein Bcl-xL.
    Kneissl S; Loveridge EJ; Williams C; Crump MP; Allemann RK
    Chembiochem; 2008 Dec; 9(18):3046-54. PubMed ID: 19012295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
    Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.
    Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD
    ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator.
    Wang H; Takemoto C; Akasaka R; Uchikubo-Kamo T; Kishishita S; Murayama K; Terada T; Chen L; Liu ZJ; Wang BC; Sugano S; Tanaka A; Inoue M; Kigawa T; Shirouzu M; Yokoyama S
    J Struct Biol; 2009 Apr; 166(1):32-7. PubMed ID: 19135534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization of BH4-truncated Bcl-x(L) in solution.
    Wang Y; Cao R; Liu D; Chervin A; Yuan J; An J; Huang Z
    Biochem Biophys Res Commun; 2007 Oct; 361(4):1006-11. PubMed ID: 17692289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
    Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
    Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
    Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and helical structure of lactam bridged BH3 peptides derived from pro-apoptotic Bcl-2 family proteins.
    Yang B; Liu D; Huang Z
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1403-6. PubMed ID: 15006371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
    Lama D; Sankararamakrishnan R
    J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.
    Joseph MK; Solomon LR; Petros AM; Cai J; Simmer RL; Zhang H; Rosenberg S; Ng SC
    Oncogene; 2004 Jan; 23(3):835-8. PubMed ID: 14737118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paralog-selective ligands for bcl-2 proteins.
    Gemperli AC; Rutledge SE; Maranda A; Schepartz A
    J Am Chem Soc; 2005 Feb; 127(6):1596-7. PubMed ID: 15700967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.
    Yin H; Hamilton AD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the membrane orientation and secondary structure of the C-terminal domains of Bak and Bcl-2 by lipids.
    Torrecillas A; Martínez-Senac MM; Goormaghtigh E; de Godos A; Corbalán-García S; Gómez-Fernández JC
    Biochemistry; 2005 Aug; 44(32):10796-809. PubMed ID: 16086582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of backbone space in foldamers containing alpha- and beta-amino acid residues: developing protease-resistant oligomers that bind tightly to the BH3-recognition cleft of Bcl-xL.
    Sadowsky JD; Murray JK; Tomita Y; Gellman SH
    Chembiochem; 2007 May; 8(8):903-16. PubMed ID: 17503422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies of phenanthridine-based Bcl-XL inhibitors.
    Bernardo PH; Wan KF; Sivaraman T; Xu J; Moore FK; Hung AW; Mok HY; Yu VC; Chai CL
    J Med Chem; 2008 Nov; 51(21):6699-710. PubMed ID: 18925736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.